Stimulant and SSRI Medication Trends in ADHD
Abstract
Prescription trends for stimulants, selective serotonin reuptake inhibitors (SSRI), and combination therapies for ADHD, comorbid and emotional disorders were evaluated by a retrospective population-based analysis of North Carolina Medicaid prescription claim files for the years 1992-1998.
DOI: https://doi.org/10.15844/pedneurbriefs-15-6-2 | Journal eISSN: 2166-6482
Language: English
Page range: 42 - 42
Published on: Jun 1, 2001
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.